RELATED CONTENT
NEWS
- Pfizer and partners pull plug on bapineuzumab for Alzheimer's after second Phase III failure
- StemCells stock doubles on preclinical Alzheimer's data
- Medtech deep brain probe could leapfrog drugs in Alzheimer/neuro opportunity
- J&J investor day: A club drug for depression and an Alzheimer's pledge
COMMENT
Other Informa Comment

